123 related articles for article (PubMed ID: 17261766)
1. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
Ho SM; Leung YK; Chung I
Ann N Y Acad Sci; 2006 Nov; 1089():177-93. PubMed ID: 17261766
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Study of the Impact of Estrogens and Selective Estrogen Receptor Modulators on Prostate Cancer Cell Proliferation.
Lafront C; Germain L; Weidmann C; Audet-Walsh É
Sci Rep; 2020 Mar; 10(1):4024. PubMed ID: 32132580
[TBL] [Abstract][Full Text] [Related]
3. Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.
Lau KM; To KF
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589731
[TBL] [Abstract][Full Text] [Related]
4. The role of estrogens and estrogen receptors in normal prostate growth and disease.
Prins GS; Korach KS
Steroids; 2008 Mar; 73(3):233-44. PubMed ID: 18093629
[TBL] [Abstract][Full Text] [Related]
5. The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression.
Lafront C; Germain L; Campolina-Silva GH; Weidmann C; Berthiaume L; Hovington H; Brisson H; Jobin C; Frégeau-Proulx L; Cotau R; Gonthier K; Lacouture A; Caron P; Ménard C; Atallah C; Riopel J; Latulippe É; Bergeron A; Toren P; Guillemette C; Pelletier M; Fradet Y; Belleannée C; Pouliot F; Lacombe L; Lévesque É; Audet-Walsh É
J Clin Invest; 2024 Apr; 134(11):. PubMed ID: 38625747
[TBL] [Abstract][Full Text] [Related]
6. New mode of action of curcumin on prostate cancer cells: Modulation of endoplasmic reticulum-associated degradation mechanism and estrogenic signaling.
Erzurumlu Y; Dogan HK; Catakli D
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23636. PubMed ID: 38229314
[TBL] [Abstract][Full Text] [Related]
7. Regulation of estrogen receptor beta activity and implications in health and disease.
Swedenborg E; Power KA; Cai W; Pongratz I; Rüegg J
Cell Mol Life Sci; 2009 Dec; 66(24):3873-94. PubMed ID: 19669093
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development.
Liu X; Tang J; Peng L; Nie H; Zhang Y; Liu P
Apoptosis; 2023 Jun; 28(5-6):881-891. PubMed ID: 37000314
[TBL] [Abstract][Full Text] [Related]
9. Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers.
Chimento A; De Luca A; Avena P; De Amicis F; Casaburi I; Sirianni R; Pezzi V
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163166
[TBL] [Abstract][Full Text] [Related]
10. Exploration in the Mechanism of Action of Licorice by Network Pharmacology.
Chen M; Zhu J; Kang J; Lai X; Gao Y; Gan H; Yang F
Molecules; 2019 Aug; 24(16):. PubMed ID: 31443210
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Endocrine Disruption Activity of Deposits on Firefighting Gear Using a Sensitive and High Throughput Screening Method.
Stevenson M; Alexander B; Baxter CS; Leung YK
J Occup Environ Med; 2015 Dec; 57(12):e153-7. PubMed ID: 26641839
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Exhibits a Biphasic Effect on Prostate Tumor Growth through the Estrogen Receptor β-KLF5 Pathway.
Nakajima Y; Osakabe A; Waku T; Suzuki T; Akaogi K; Fujimura T; Homma Y; Inoue S; Yanagisawa J
Mol Cell Biol; 2016 Jan; 36(1):144-56. PubMed ID: 26483416
[TBL] [Abstract][Full Text] [Related]
13. A biospectroscopic analysis of human prostate tissue obtained from different time periods points to a trans-generational alteration in spectral phenotype.
Theophilou G; Lima KM; Briggs M; Martin-Hirsch PL; Stringfellow HF; Martin FL
Sci Rep; 2015 Aug; 5():13465. PubMed ID: 26310632
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer potential of a novel SERM ormeloxifene.
Gara RK; Sundram V; Chauhan SC; Jaggi M
Curr Med Chem; 2013; 20(33):4177-84. PubMed ID: 23895678
[TBL] [Abstract][Full Text] [Related]
15. The association between estrogen receptor alpha polymorphisms and the risk of prostate cancer in Slovak population.
Jurečeková J; Sivoňová MK; Evinová A; Kliment J; Dobrota D
Mol Cell Biochem; 2013 Sep; 381(1-2):201-7. PubMed ID: 23737135
[TBL] [Abstract][Full Text] [Related]
16. High circulating estrogens and selective expression of ERβ in prostate tumors of Americans: implications for racial disparity of prostate cancer.
Abd Elmageed ZY; Moroz K; Srivastav SK; Fang Z; Crawford BE; Moparty K; Thomas R; Abdel-Mageed AB
Carcinogenesis; 2013 Sep; 34(9):2017-23. PubMed ID: 23658372
[TBL] [Abstract][Full Text] [Related]
17. Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex.
Re A; Aiello A; Nanni S; Grasselli A; Benvenuti V; Pantisano V; Strigari L; Colussi C; Ciccone S; Mazzetti AP; Pierconti F; Pinto F; Bassi P; Gallucci M; Sentinelli S; Trimarchi F; Bacchetti S; Pontecorvi A; Lo Bello M; Farsetti A
Mol Endocrinol; 2011 Dec; 25(12):2003-16. PubMed ID: 22052999
[TBL] [Abstract][Full Text] [Related]
18. Estrogens and prostate cancer: etiology, mediators, prevention, and management.
Ho SM; Lee MT; Lam HM; Leung YK
Endocrinol Metab Clin North Am; 2011 Sep; 40(3):591-614, ix. PubMed ID: 21889723
[TBL] [Abstract][Full Text] [Related]
19. Cancer biomarker discovery: the entropic hallmark.
Berretta R; Moscato P
PLoS One; 2010 Aug; 5(8):e12262. PubMed ID: 20805891
[TBL] [Abstract][Full Text] [Related]
20. Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer.
Montgomery B; Nelson PS; Vessella R; Kalhorn T; Hess D; Corey E
BMC Cancer; 2010 May; 10():244. PubMed ID: 20509933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
